Investigational lung cancer treatment shows strong anti-tumour activity in brain mestastases
10/02/2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) has announced updated clinical results on its investigational tyrosine kinase inhibitor (TKI), AP26113, in patients with advanced non-small cell lung cancer (NSCLC) from an ongoing Phase 1/2 trial...
Investigational lung cancer treatment shows strong anti-tumour activity in brain mestastases
10/02/2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) has announced updated clinical results on its investigational tyrosine kinase inhibitor (TKI), AP26113, in patients with advanced non-small cell lung cancer (NSCLC) from an ongoing Phase 1/2 trial...
A new test for genetic markers that can identify which lumps in the thyroid gland are cancerous and which are harmless - potentially preventing unneeded operations - will make its debut Oct. 1 for patients seeking care at the UPMC/UPCI Multidisciplinary Thyroid Center (MTC)...
Castle Biosciences launches tissue repository for eye cancer patients
10/02/2013
Castle Biosciences Inc. has announced the availability of a tumor tissue repository for patients whose tumors are being tested with the Company's gene test for uveal, or ocular, melanoma. Patients will now have the option of storing an additional sample of their tumor free of charge for up to five years, and will be able to access it to take advantage of future developments in the disease...
More research urged to compare and validate genomic tests for patients with early breast cancer
10/02/2013
The European Society for Medical Oncology (ESMO) has welcomed preliminary clinical trial results that suggest genomic testing could allow many patients with early breast cancer to safely avoid chemotherapy...
Nanosphere, Inc...
Dealing with side-effects of hormone therapy for prostate cancer
10/02/2013
Flushed face, sweating, a sudden rush of heat. The hot flash, the bane of menopausal women, also can affect men who are undergoing hormone therapy for prostate cancer. But unlike in women, neither soy protein nor a common antidepressant provides relief for men, according to researchers at Wake Forest Baptist Medical Center...
Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results presented at the 2013 European Cancer Congress (ECC2013) [1]...
Aspirin may act on two different pathways to improve survival in colon cancer
10/02/2013
Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard. Although previous research has shown that taking low dose aspirin after being diagnosed with colon cancer improves patient outcome, the reasons why this happens remain unknown...
Abnormal DNA methylation precedes cancer initiation: non-invasive tests a future possibility
10/02/2013
Unique DNA markings on certain genes may "predict" the risk of developing head and neck cancer, according to new research led by Queen Mary University of London. The findings, published in the journal Cancer, raise the potential for the development of non-invasive tests which could pick up these tell-tale signs of early cancer initiation...